| Literature DB >> 34336923 |
Bruce R Southey1, Courtni R Bolt1, Haley E Rymut1, Marissa R Keever1, Alexander V Ulanov2, Zhong Li2, Laurie A Rund1, Rodney W Johnson1,3, Sandra L Rodriguez-Zas1,3,4,5.
Abstract
Weaning wields environmental, social, and nutritional stresses that are detectable in the blood metabolite levels of the offspring. Prenatal stress in the form of maternal immune activation (MIA) in response to infection, which is associated with health and behavior disorders, also elicits prolonged changes in blood and brain cytokine and metabolite levels of the offspring. The goal of this study was to investigate the effects of weaning and MIA on the offspring's liver function to advance the understanding of the impact of stressors on peripheral and central nervous systems, physiology, and health. Gas chromatography-mass spectrometry analysis was used to compare the level of hepatic metabolites from 22-day-old pigs (n = 48) evenly distributed among weaning (nursed or weaned), viral MIA exposure (yes or no), and sexes. Weaning effects were detected on 38 metabolites at p-value < 0.05 (28 metabolites at FDR p-value < 0.05), and sex-dependent MIA effects were detected on 11 metabolites. Multiple intermediate and final products of the enriched (FDR p-value < 0.05) glycolysis and gluconeogenesis and pentose phosphate pathways were over-abundant in nursed relative to weaned pigs. The enriched pathways confirm the impact of weaning on hepatic metabolic shift, oxidative stress, and inflammation. Higher levels of the glucogenic amino acid histidine are observed in pigs exposed to MIA relative to controls, suggesting that the role of this metabolite in modulating inflammation may supersede the role of this amino acid as an energy source. The lower levels of cholesterol detected in MIA pigs are consistent with hypocholesterolemia profiles detected in individuals with MIA-related behavior disorders. Our findings underline the impact of weaning and MIA stressors on hepatic metabolites that can influence peripheral and central nervous system metabolic products associated with health and behavior disorders.Entities:
Keywords: gas chromatography; hepatic metabolomics stress; mass spectrometry; maternal immune activation; weaning
Year: 2021 PMID: 34336923 PMCID: PMC8319725 DOI: 10.3389/fmolb.2021.660764
Source DB: PubMed Journal: Front Mol Biosci ISSN: 2296-889X
Metabolites presenting at least one effect, weaning alone or interacting with maternal immune activation or sex, at p-value < 0.05.
|
| ||||||||
|---|---|---|---|---|---|---|---|---|
| Metabolite | Path | W | M | S | MxS | MxW | WxS | WxMxS |
| (S)-2-Hydroxyglutarate | F | 0.252 | 0.704 | 0.044 | 0.536 | 0.374 | 0.968 | 0.670 |
| 2-Hydroxybutyric acid | F | 5.67E-12 | 0.097 | 0.378 | 0.264 | 0.192 | 0.693 | 0.484 |
| 2-Hydroxypropanamide | U | 0.031 | 0.188 | 0.992 | 0.362 | 0.943 | 0.734 | 0.810 |
| 3-Aminoisobutanoic acid | A | 8.81E-11 | 0.489 | 0.967 | 0.259 | 0.354 | 0.604 | 0.368 |
| 3-Hydroxybutyric acid | F | 1.67E-06 | 0.320 | 0.556 | 0.153 | 0.555 | 0.917 | 0.650 |
| 3-Phosphoglyceric acid | C | 0.042 | 0.865 | 0.997 | 0.502 | 0.362 | 0.622 | 0.982 |
| 5′-Methylthioadenosine | A | 3.24E-04 | 0.910 | 0.548 | 0.165 | 0.327 | 0.139 | 0.170 |
| Adenosine-3-monophosphate | P | 0.028 | 0.423 | 0.526 | 0.035 | 0.417 | 0.853 | 0.496 |
| Arachidyl alcohol | F | 0.889 | 0.089 | 0.255 | 0.935 | 0.368 | 0.041 | 0.287 |
| Benzoic acid | A | 0.003 | 0.865 | 0.189 | 0.595 | 0.783 | 0.498 | 0.934 |
| beta-Alanine | A | 0.028 | 0.266 | 0.233 | 0.321 | 0.441 | 0.897 | 0.950 |
| beta-Glycerophosphoric acid | F | 0.014 | 0.865 | 0.595 | 0.430 | 0.783 | 0.055 | 0.592 |
| Citric acid | C | 0.018 | 0.744 | 0.095 | 0.582 | 0.160 | 0.682 | 0.530 |
| Creatinine | A | 2.57E-04 | 0.853 | 0.225 | 0.862 | 0.676 | 0.350 | 0.335 |
|
| C | 0.034 | 0.303 | 0.843 | 0.821 | 0.561 | 0.171 | 1.000 |
|
| C | 0.008 | 0.384 | 0.940 | 0.628 | 0.633 | 0.598 | 0.733 |
|
| C | 1.41E-04 | 0.665 | 0.609 | 0.607 | 0.257 | 0.459 | 0.747 |
|
| C | 0.009 | 0.754 | 0.014 | 0.570 | 0.370 | 0.680 | 0.907 |
| Diethylene glycol | F | 0.022 | 0.932 | 0.995 | 0.908 | 0.723 | 0.441 | 0.420 |
| Ethanolamine | F | 0.008 | 0.660 | 0.353 | 0.159 | 0.442 | 0.846 | 0.921 |
| Ethanolamine glycerophosphate | C | 0.041 | 0.391 | 0.309 | 0.480 | 0.139 | 0.454 | 0.652 |
| Fructose 6-phosphate | C | 1.09E-06 | 0.583 | 0.004 | 0.501 | 0.352 | 0.132 | 0.881 |
| gamma-Aminobutyric acid | A | 0.026 | 0.382 | 0.278 | 0.153 | 0.649 | 0.347 | 0.691 |
| Glucose 6-phosphate | C | 1.75E-07 | 0.394 | 0.290 | 0.802 | 0.829 | 0.754 | 0.253 |
| Glutathione | A | 0.014 | 0.378 | 0.266 | 0.865 | 0.668 | 0.219 | 0.075 |
| Glycerophosphoglycerol | F | 0.018 | 0.273 | 0.032 | 0.244 | 0.166 | 0.195 | 0.666 |
| Glycine | A | 1.83E-04 | 0.420 | 0.494 | 0.367 | 0.707 | 0.811 | 0.865 |
| Glyoxylic acid | A | 0.001 | 0.288 | 0.458 | 0.053 | 0.508 | 0.031 | 0.405 |
| Guanine | P | 0.012 | 0.441 | 0.846 | 0.524 | 0.653 | 0.369 | 0.137 |
| Guanosine | P | 0.006 | 0.306 | 0.268 | 0.395 | 0.430 | 0.580 | 0.777 |
| Hypoxanthine | P | 0.009 | 0.332 | 0.942 | 0.563 | 0.531 | 0.892 | 0.883 |
| Inositol (unidentified) | C | 0.005 | 0.377 | 0.732 | 0.402 | 0.223 | 0.681 | 0.451 |
| Inositol phosphate | U | 0.048 | 0.483 | 0.233 | 0.192 | 0.261 | 0.763 | 0.721 |
|
| A | 0.007 | 0.325 | 0.801 | 0.573 | 0.647 | 0.773 | 0.247 |
|
| A | 0.028 | 0.967 | 0.065 | 0.545 | 0.462 | 0.903 | 0.840 |
|
| A | 0.016 | 0.435 | 0.551 | 0.323 | 0.793 | 0.724 | 0.243 |
|
| A | 8.41E-05 | 0.892 | 0.292 | 0.961 | 0.792 | 0.177 | 0.522 |
|
| A | 0.002 | 0.034 | 0.110 | 0.568 | 0.833 | 0.325 | 0.843 |
|
| A | 0.004 | 0.503 | 0.449 | 0.086 | 0.935 | 0.692 | 0.615 |
|
| C | 0.013 | 0.545 | 0.566 | 0.656 | 0.626 | 0.826 | 0.868 |
|
| A | 2.70E-06 | 0.772 | 0.875 | 0.796 | 0.583 | 0.998 | 0.556 |
| Malic acid | C | 0.003 | 0.218 | 0.140 | 0.627 | 0.761 | 0.920 | 0.859 |
| N-Acetylneuraminic acid | C | 0.003 | 0.983 | 0.242 | 0.271 | 0.683 | 0.876 | 0.622 |
| N-Methyl- | A | 4.19E-09 | 0.508 | 0.754 | 0.662 | 0.967 | 0.699 | 0.256 |
| O-Phosphoethanolamine | F | 0.022 | 0.258 | 0.390 | 0.494 | 0.065 | 0.738 | 0.599 |
| Ornithine | A | 0.024 | 0.999 | 0.913 | 0.222 | 0.915 | 0.487 | 0.647 |
| Putrescine | A | 0.005 | 0.984 | 0.277 | 0.315 | 0.879 | 0.332 | 0.962 |
| Sedoheptulose | C | 0.002 | 0.703 | 0.508 | 0.829 | 0.682 | 0.197 | 0.138 |
| Succinic acid | C | 0.002 | 0.465 | 0.197 | 0.890 | 0.519 | 0.812 | 0.938 |
| Threonic acid lactone | C | 0.865 | 0.911 | 0.241 | 0.136 | 0.510 | 0.006 | 0.232 |
p-value for weaning (W), MIA (M), sex (S), interaction between MIA and sex (MxS), interaction between MIA and weaning (MxW), interaction between weaning and sex (WxS), and interaction between weaning, MIA, and sex (WxMxS). p-value < 0.01 = FDR-adjusted p-value < 0.05; p-value < 0.05 = FDR-adjusted p-value < 0.15.
2Metabolic pathway or classification: A = amino acid metabolism; C = carbohydrate metabolism; F = fatty acid metabolism; G = glycoprotein; P = purine and pyrimidine; U = unknown.
FIGURE 1Abundance profile across weaning, maternal immune activation, and sex groups for metabolites that presented weaning effect alone or interacting with other factors.
Pathways enriched at p-value < 0.05 and including at least three metabolites among the molecules associated with weaning effects.
| Database | Category | Total | Hits |
| FDR |
|---|---|---|---|---|---|
| MBDDB | Diabetes mellitus (MODY), non-insulin-dependent | 19 | 7 | 3.4E-4 | 0.050 |
| SMPDB | Warburg effect | 58 | 8 | 0.001 | 0.099 |
| SMPDB | Ammonia recycling | 32 | 5 | 0.006 | 0.217 |
| KEGG | Aminoacyl-tRNA biosynthesis | 48 | 8 | 1.6E-5 | 0.001 |
| KEGG | Alanine, aspartate, and glutamate metabolism | 28 | 6 | 4.8E-5 | 0.002 |
| KEGG | Starch and sucrose metabolism | 18 | 5 | 5.7E-5 | 0.002 |
| KEGG | Arginine biosynthesis | 14 | 3 | 0.005 | 0.078 |
| KEGG | Glyoxylate and dicarboxylate metabolism | 32 | 4 | 0.008 | 0.108 |
| KEGG | Amino sugar and nucleotide sugar metabolism | 37 | 4 | 0.013 | 0.126 |
| KEGG | Arginine and proline metabolism | 38 | 4 | 0.015 | 0.126 |
| KEGG | beta-Alanine metabolism | 21 | 3 | 0.015 | 0.126 |
| KEGG | Pentose phosphate pathway | 22 | 3 | 0.017 | 0.131 |
| KEGG | Propanoate metabolism | 23 | 3 | 0.019 | 0.135 |
| KEGG | Galactose metabolism | 27 | 3 | 0.029 | 0.192 |
| KEGG | Glutathione metabolism | 28 | 3 | 0.033 | 0.196 |
MBDDB = MetaboAnalyst Blood Disease Database; SMPDB = Small Molecule Pathway Database; KEGG = Kyoto Encyclopedia of Genes and Genomes database.
Total number of metabolites in the category.
Hits = number of differentially abundant metabolites in the category.
FDR = false discovery rate–adjusted p-value.
Metabolites presenting at least one effect, maternal immune activation alone or interacting with weaning or sex, at p-value < 0.05.
|
| ||||||||
|---|---|---|---|---|---|---|---|---|
| Metabolite | Path | W | M | S | MxS | MxW | WxS | WxMxS |
| N-Acetyltryptophan | A | 0.300 | 0.052 | 0.310 | 0.088 | 0.013 | 0.450 | 0.002 |
| Cholesterol | F | 0.300 | 0.003 | 0.076 | 0.069 | 0.790 | 0.470 | 0.230 |
| Glycolic acid | F | 0.390 | 0.880 | 0.520 | 0.006 | 0.930 | 0.430 | 0.380 |
| Palmitic acid | F | 0.720 | 0.150 | 0.590 | 0.019 | 0.940 | 0.900 | 0.140 |
| alpha-Lactose | C | 0.280 | 0.015 | 0.420 | 0.620 | 0.310 | 0.970 | 0.270 |
| Mannitol | C | 0.250 | 0.300 | 0.570 | 0.015 | 0.270 | 0.560 | 0.280 |
| Stearic acid | F | 0.850 | 0.100 | 0.200 | 0.021 | 0.910 | 0.730 | 0.490 |
| 3′-AMP | P | 0.028 | 0.420 | 0.530 | 0.035 | 0.420 | 0.850 | 0.500 |
| Methylcysteine | A | 0.053 | 0.670 | 0.340 | 0.034 | 0.970 | 0.700 | 0.560 |
|
| A | 0.900 | 0.930 | 0.270 | 0.047 | 0.790 | 0.490 | 0.410 |
| Linoleic acid | F | 0.520 | 0.390 | 0.650 | 0.041 | 0.890 | 0.370 | 0.870 |
|
| A | 0.002 | 0.034 | 0.110 | 0.570 | 0.830 | 0.330 | 0.840 |
| Aminoadipic acid | A | 0.380 | 0.046 | 0.270 | 0.350 | 0.350 | 0.620 | 0.820 |
p-value for weaning (W), MIA (M), sex (S), interaction between MIA and sex (MxS), interaction between MIA and weaning (MxW), interaction between weaning and sex (WxS), and interaction between weaning, MIA, and sex (WxMxS). p-value < 0.01 = FDR-adjusted p-value < 0.05; p-value < 0.05 = FDR-adjusted p-value < 0.15.
Metabolic pathway or classification: A = amino acid metabolism; C = carbohydrate metabolism; F = fatty acid metabolism; G = glycoprotein; P = purine and pyrimidine; U = unknown.
FIGURE 2Abundance profile across weaning, maternal immune activation, and sex groups for metabolites that presented maternal immune activation effect alone or interacting with other factors.
Pathways enriched at p-value < 0.05 and including at least three metabolites among the molecules associated with maternal immune activation effects.
| Source | Category | Total | Hits |
| FDR |
|---|---|---|---|---|---|
| SMPDB | Bile acid biosynthesis | 65 | 3 | 0.044 | >0.25 |
| KEGG | Biosynthesis of unsaturated fatty acids | 36 | 3 | 0.003 | 0.248 |
SMPDB = Small Molecule Pathway Database; KEGG = Kyoto Encyclopedia of Genes and Genomes database.
Total number of metabolites in the category.
Hits = number of differentially abundant metabolites in the category.
FDR = false discovery rate–adjusted p-value.